Papers
1
Total Citations
26
H-Index
1
About
Dr. Ryota Aki is a pioneering urologic surgeon whose work centers on advancing minimally invasive surgical techniques for renal cancer treatment. His major contributions lie in the comparative assessment of robot-assisted partial nephrectomy (RAPN) versus conventional open partial nephrectomy (OPN), with a focus on improving patient outcomes through reduced morbidity. His landmark 2019 study, “Early Single-Center Experience with Robotic Partial Nephrectomy Using the da Vinci Xi,” has garnered 26 citations, highlighting its influence in shaping clinical practice. By demonstrating that RAPN offers comparable oncologic efficacy with enhanced recovery and lower complication rates, Dr. Aki has helped drive the adoption of robotic surgery in urology. His work underscores a commitment to evidence-based innovation, bridging the gap between emerging technology and real-world patient care. For students and researchers, Dr. Aki’s research exemplifies how rigorous comparative studies can validate novel surgical approaches, paving the way for safer, more effective treatments in renal oncology.
Research Focus
Key Achievements
Top Papers
- 1